Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Metcalfe

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
The New Zealand Medical Journal|October 29, 2003
Direct-to-consumer advertising--yes it can compromise patient healthScott Metcalfe, Wayne McNee, Peter Moodie
Pharmacoeconomics|September 17, 2008
Funding a clinical trial: the perspective of a medicines funderPeter Alsop, Scott Metcalfe, Jackie Evans
Healthcarepapers|June 18, 2003
Our advice? Get a budget!Matthew Brougham, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|July 20, 2005
PHARMAC welcomes debatePeter Moodie, Wayne McNee, Scott Metcalfe
The New Zealand Medical Journal|March 15, 2006
PHARMAC responds on agents to prevent osteoporotic fracturesScott Metcalfe, Tommy Wilkinson, Dilky Rasiah
The New Zealand Medical Journal|June 2, 2017
A kick in the butt: time to address tobacco waste in New ZealandScott Metcalfe, Peter Murray, Carsten Schousboe
The New Zealand Medical Journal|March 27, 2003
Response from PHARMAC: difficult choicesPeter Moodie, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|July 27, 2006
PHARMAC and statins--getting the best population health gainsPeter Moodie, Sean Dougherty, Scott Metcalfe
The New Zealand Medical Journal|June 28, 2005
PHARMAC and tobacco control in New Zealand: two licensed funded options are already availableScott Metcalfe, Peter Moodie, Wayne McNee
The New Zealand Medical Journal|June 26, 2007
PHARMAC funding of 9-week concurrent trastuzumab (Herceptin) for HER2-positive early breast cancerScott Metcalfe, Jackie Evans, Ginny Priest
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The New Zealand Medical Journal|October 29, 2003
Direct-to-consumer advertising--yes it can compromise patient healthScott Metcalfe, Wayne McNee, Peter Moodie
Pharmacoeconomics|September 17, 2008
Funding a clinical trial: the perspective of a medicines funderPeter Alsop, Scott Metcalfe, Jackie Evans
Healthcarepapers|June 18, 2003
Our advice? Get a budget!Matthew Brougham, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|July 20, 2005
PHARMAC welcomes debatePeter Moodie, Wayne McNee, Scott Metcalfe
The New Zealand Medical Journal|March 15, 2006
PHARMAC responds on agents to prevent osteoporotic fracturesScott Metcalfe, Tommy Wilkinson, Dilky Rasiah
The New Zealand Medical Journal|June 2, 2017
A kick in the butt: time to address tobacco waste in New ZealandScott Metcalfe, Peter Murray, Carsten Schousboe
The New Zealand Medical Journal|March 27, 2003
Response from PHARMAC: difficult choicesPeter Moodie, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|July 27, 2006
PHARMAC and statins--getting the best population health gainsPeter Moodie, Sean Dougherty, Scott Metcalfe
The New Zealand Medical Journal|June 28, 2005
PHARMAC and tobacco control in New Zealand: two licensed funded options are already availableScott Metcalfe, Peter Moodie, Wayne McNee
The New Zealand Medical Journal|June 26, 2007
PHARMAC funding of 9-week concurrent trastuzumab (Herceptin) for HER2-positive early breast cancerScott Metcalfe, Jackie Evans, Ginny Priest
Pageof 7